Keith Unger

Summary

Affiliation: Georgetown University
Country: USA

Publications

  1. pmc CyberKnife for hilar lung tumors: report of clinical response and toxicity
    Keith Unger
    Department of Radiation Medicine, Georgetown University Hospital, Washington, DC, USA
    J Hematol Oncol 3:39. 2010
  2. pmc CyberKnife enhanced conventionally fractionated chemoradiation for high grade glioma in close proximity to critical structures
    Eric Oermann
    Department of Radiation Oncology, Georgetown University Hospital, Washington, DC, USA
    J Hematol Oncol 3:22. 2010
  3. pmc Scoring system predictive of survival for patients undergoing stereotactic body radiation therapy for liver tumors
    Marie Adele S Kress
    Department of Radiation Oncolog, Georgetown University Hospital, Lower Level Bles, 3800 Reservoir Road, Georgetown, NW Washington, DC 20007, USA
    Radiat Oncol 7:148. 2012
  4. pmc Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach
    Beant Gill
    Department of Radiation Medicine, Georgetown University Hospital, Washington, DC, USA
    Front Oncol 2:39. 2012
  5. pmc Stereotactic body radiation therapy for liver metastases from colorectal cancer: analysis of safety, feasibility, and early outcomes
    Marie Adele S Kress
    Department of Radiation Oncology, Georgetown University Washington, DC, USA
    Front Oncol 2:8. 2012
  6. ncbi request reprint Histopathologic effects of hypofractionated robotic radiation therapy on malignant and benign prostate tissue
    Simeng Suy
    Department of Radiation Medicine, Georgetown University Hospital
    Technol Cancer Res Treat 9:583-7. 2010

Collaborators

Detail Information

Publications6

  1. pmc CyberKnife for hilar lung tumors: report of clinical response and toxicity
    Keith Unger
    Department of Radiation Medicine, Georgetown University Hospital, Washington, DC, USA
    J Hematol Oncol 3:39. 2010
    ..To report clinical efficacy and toxicity of fractionated CyberKnife radiosurgery for the treatment of hilar lung tumors...
  2. pmc CyberKnife enhanced conventionally fractionated chemoradiation for high grade glioma in close proximity to critical structures
    Eric Oermann
    Department of Radiation Oncology, Georgetown University Hospital, Washington, DC, USA
    J Hematol Oncol 3:22. 2010
    ..We investigated the safety and efficacy of utilizing highly conformal and precise CyberKnife radiotherapy to enhance conventional radiotherapy in the treatment of high grade glioma...
  3. pmc Scoring system predictive of survival for patients undergoing stereotactic body radiation therapy for liver tumors
    Marie Adele S Kress
    Department of Radiation Oncolog, Georgetown University Hospital, Lower Level Bles, 3800 Reservoir Road, Georgetown, NW Washington, DC 20007, USA
    Radiat Oncol 7:148. 2012
    ..Stereotactic body radiation therapy (SBRT) is an emerging treatment option for liver tumors. This study evaluated outcomes after SBRT to identify prognostic variables and to develop a novel scoring system predictive of survival...
  4. pmc Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach
    Beant Gill
    Department of Radiation Medicine, Georgetown University Hospital, Washington, DC, USA
    Front Oncol 2:39. 2012
    ..A prospective study aimed at further enhancing local control by targeting the intact VB and escalating the total dose is planned...
  5. pmc Stereotactic body radiation therapy for liver metastases from colorectal cancer: analysis of safety, feasibility, and early outcomes
    Marie Adele S Kress
    Department of Radiation Oncology, Georgetown University Washington, DC, USA
    Front Oncol 2:8. 2012
    ..Further studies are needed to better define patient eligibility, study the role of combined modality treatment, optimize treatment parameters, and characterize quality of life after treatment...
  6. ncbi request reprint Histopathologic effects of hypofractionated robotic radiation therapy on malignant and benign prostate tissue
    Simeng Suy
    Department of Radiation Medicine, Georgetown University Hospital
    Technol Cancer Res Treat 9:583-7. 2010
    ..There was no evidence of residual cancer, fibrosis or necrosis. The patient's postoperative course was uneventful with post-treatment PSA of 0.5 ng/ml and residual grade 1 stress incontinence...